Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (6): 601-608.DOI: 10.3969/j.issn.1673-8640.2020.06.018
Previous Articles Next Articles
ZHANG Qiang1, LIN Jing1, ZONG Xiaolong2, SUN Guang3, LIU Junfeng4()
Received:
2019-11-11
Online:
2020-06-30
Published:
2020-07-01
CLC Number:
ZHANG Qiang, LIN Jing, ZONG Xiaolong, SUN Guang, LIU Junfeng. Clinical evaluation of homemade Precil C3510 automatic coagulation analyzer for routine coagulation parameters[J]. Laboratory Medicine, 2020, 35(6): 601-608.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.06.018
项目 | $\bar{x}$ | 批内不精密度 | 实验室内总不精密度 | 允许范围/% | |||||
---|---|---|---|---|---|---|---|---|---|
MS批内 | s批内 | CV/% | MS批间 | s总 | CV% | ||||
生理值质控品 | |||||||||
PT/s | 11.84 | 0.026 | 0.16 | 1.35 | 0.06 | 0.18 | 1.53 | ±3 | |
INR | 0.96 | 0.000 27 | 0.016 | 1.71 | 0.000 65 | 0.019 | 1.93 | ±3 | |
APTT/s | 36.27 | 0.35 | 0.59 | 1.63 | 0.51 | 0.62 | 1.70 | ±4 | |
Fib/(g/L) | 2.72 | 0.017 | 0.13 | 4.79 | 0.011 | 0.13 | 4.79 | ±8 | |
DD/(mg/L) | 0.68 | 0.001 4 | 0.037 | 5.50 | 0.004 3 | 0.044 | 6.54 | ±10 | |
病理值质控品 | |||||||||
PT/s | 38.1 | 1.94 | 1.39 | 3.65 | 5.85 | 1.65 | 4.34 | ±8 | |
INR | 3.92 | 0.024 | 0.15 | 3.83 | 0.07 | 0.18 | 4.63 | ±8 | |
APTT/s | 69.63 | 6.28 | 2.51 | 3.60 | 40.03 | 3.61 | 5.19 | ±8 | |
Fib/(g/L) | 1.87 | 0.008 4 | 0.084 | 5.35 | 0.007 | 0.092 | 5.86 | ±15 | |
DD/(mg/L) | 1.83 | 0.02 | 0.14 | 7.73 | 0.084 | 0.18 | 9.90 | ±15 |
项目 | $\bar{x}$ | 批内不精密度 | 实验室内总不精密度 | 允许范围/% | |||||
---|---|---|---|---|---|---|---|---|---|
MS批内 | s批内 | CV/% | MS批间 | s总 | CV% | ||||
生理值质控品 | |||||||||
PT/s | 11.84 | 0.026 | 0.16 | 1.35 | 0.06 | 0.18 | 1.53 | ±3 | |
INR | 0.96 | 0.000 27 | 0.016 | 1.71 | 0.000 65 | 0.019 | 1.93 | ±3 | |
APTT/s | 36.27 | 0.35 | 0.59 | 1.63 | 0.51 | 0.62 | 1.70 | ±4 | |
Fib/(g/L) | 2.72 | 0.017 | 0.13 | 4.79 | 0.011 | 0.13 | 4.79 | ±8 | |
DD/(mg/L) | 0.68 | 0.001 4 | 0.037 | 5.50 | 0.004 3 | 0.044 | 6.54 | ±10 | |
病理值质控品 | |||||||||
PT/s | 38.1 | 1.94 | 1.39 | 3.65 | 5.85 | 1.65 | 4.34 | ±8 | |
INR | 3.92 | 0.024 | 0.15 | 3.83 | 0.07 | 0.18 | 4.63 | ±8 | |
APTT/s | 69.63 | 6.28 | 2.51 | 3.60 | 40.03 | 3.61 | 5.19 | ±8 | |
Fib/(g/L) | 1.87 | 0.008 4 | 0.084 | 5.35 | 0.007 | 0.092 | 5.86 | ±15 | |
DD/(mg/L) | 1.83 | 0.02 | 0.14 | 7.73 | 0.084 | 0.18 | 9.90 | ±15 |
干扰物 | 浓度/ (mg/mL) | PT | APTT | Fib | DD | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
$\bar{x}$/s | dobs | $\bar{x}$/s | dobs | $\bar{x}$/(g/L) | dobs | $\bar{x}$/(mg/L) | dobs | |||||
对照 | 0 | 13.1 | 29.8 | 3.12 | 1.16 | |||||||
血红蛋白 | 1 | 13.2 | 0.1 | 30.3 | 0.5 | 3.06 | -0.06 | 1.16 | 0.00 | |||
2 | 13.1 | 0.0 | 30.1 | 0.3 | 3.15 | 0.03 | 1.17 | 0.01 | ||||
3 | 12.7 | -0.4 | 29.4 | -0.4 | 3.21 | 0.09 | 1.11 | -0.05 | ||||
4 | 13.4 | 0.3 | 30.6 | 0.8 | 2.98 | -0.14 | 1.08 | -0.08 | ||||
5 | 12.9 | -0.2 | 28.4 | -1.4 | 3.20 | 0.08 | 1.06 | -0.10 | ||||
三酰甘油 | 0.8 | 12.9 | -0.2 | 30.3 | 0.5 | 3.12 | 0.00 | 1.12 | -0.04 | |||
1.6 | 13.1 | 0.0 | 30.5 | 0.7 | 3.07 | -0.05 | 1.09 | -0.07 | ||||
2.4 | 13.1 | 0.0 | 28.9 | -0.9 | 3.22 | 0.10 | 0.99 | -0.17 | ||||
3.2 | 13.2 | 0.1 | 30.3 | 0.5 | 3.00 | -0.12 | 0.94 | -0.22 | ||||
4.0 | 13.3 | 0.2 | 31.1 | 1.3 | 3.19 | 0.07 | 0.86 | -0.30 | ||||
胆红素 | 0.06 | 13.5 | 0.4 | 30.0 | 0.2 | 3.11 | -0.01 | 1.15 | -0.01 | |||
0.12 | 13.3 | 0.2 | 30.2 | 0.4 | 2.91 | -0.21 | 1.18 | 0.02 | ||||
0.18 | 12.9 | -0.2 | 29.8 | 0.0 | 3.28 | 0.16 | 1.09 | -0.07 | ||||
0.24 | 13.1 | 0.0 | 31.5 | 1.7 | 2.99 | -0.13 | 1.11 | -0.05 | ||||
0.30 | 12.8 | -0.3 | 31.1 | 1.3 | 3.15 | 0.03 | 1.07 | -0.09 |
干扰物 | 浓度/ (mg/mL) | PT | APTT | Fib | DD | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
$\bar{x}$/s | dobs | $\bar{x}$/s | dobs | $\bar{x}$/(g/L) | dobs | $\bar{x}$/(mg/L) | dobs | |||||
对照 | 0 | 13.1 | 29.8 | 3.12 | 1.16 | |||||||
血红蛋白 | 1 | 13.2 | 0.1 | 30.3 | 0.5 | 3.06 | -0.06 | 1.16 | 0.00 | |||
2 | 13.1 | 0.0 | 30.1 | 0.3 | 3.15 | 0.03 | 1.17 | 0.01 | ||||
3 | 12.7 | -0.4 | 29.4 | -0.4 | 3.21 | 0.09 | 1.11 | -0.05 | ||||
4 | 13.4 | 0.3 | 30.6 | 0.8 | 2.98 | -0.14 | 1.08 | -0.08 | ||||
5 | 12.9 | -0.2 | 28.4 | -1.4 | 3.20 | 0.08 | 1.06 | -0.10 | ||||
三酰甘油 | 0.8 | 12.9 | -0.2 | 30.3 | 0.5 | 3.12 | 0.00 | 1.12 | -0.04 | |||
1.6 | 13.1 | 0.0 | 30.5 | 0.7 | 3.07 | -0.05 | 1.09 | -0.07 | ||||
2.4 | 13.1 | 0.0 | 28.9 | -0.9 | 3.22 | 0.10 | 0.99 | -0.17 | ||||
3.2 | 13.2 | 0.1 | 30.3 | 0.5 | 3.00 | -0.12 | 0.94 | -0.22 | ||||
4.0 | 13.3 | 0.2 | 31.1 | 1.3 | 3.19 | 0.07 | 0.86 | -0.30 | ||||
胆红素 | 0.06 | 13.5 | 0.4 | 30.0 | 0.2 | 3.11 | -0.01 | 1.15 | -0.01 | |||
0.12 | 13.3 | 0.2 | 30.2 | 0.4 | 2.91 | -0.21 | 1.18 | 0.02 | ||||
0.18 | 12.9 | -0.2 | 29.8 | 0.0 | 3.28 | 0.16 | 1.09 | -0.07 | ||||
0.24 | 13.1 | 0.0 | 31.5 | 1.7 | 2.99 | -0.13 | 1.11 | -0.05 | ||||
0.30 | 12.8 | -0.3 | 31.1 | 1.3 | 3.15 | 0.03 | 1.07 | -0.09 |
项目 | 线性比例 | 第1次 | 第2次 | 第3次 | $\bar{x}$ | 理论值 |
---|---|---|---|---|---|---|
Fib | 5H | 7.60 | 7.67 | 7.62 | 7.63 | 7.63 |
4H+1L | 6.12 | 5.83 | 6.01 | 5.99 | 6.24 | |
3H+2L | 5.01 | 5.07 | 4.91 | 5.00 | 4.85 | |
2H+3L | 3.70 | 3.71 | 3.64 | 3.68 | 3.47 | |
1H+4L | 2.13 | 2.18 | 2.15 | 2.15 | 2.08 | |
5L | 0.67 | 0.68 | 0.72 | 0.69 | 0.69 | |
DD | 5H | 9.49 | 9.42 | 9.55 | 9.49 | 9.49 |
4H+1L | 8.28 | 8.44 | 8.62 | 8.45 | 7.69 | |
3H+2L | 6.08 | 6.02 | 6.02 | 6.04 | 5.89 | |
2H+3L | 4.06 | 4.11 | 4.15 | 4.11 | 4.08 | |
1H+4L | 2.28 | 2.13 | 2.25 | 2.22 | 2.28 | |
5L | 0.50 | 0.47 | 0.47 | 0.48 | 0.48 |
项目 | 线性比例 | 第1次 | 第2次 | 第3次 | $\bar{x}$ | 理论值 |
---|---|---|---|---|---|---|
Fib | 5H | 7.60 | 7.67 | 7.62 | 7.63 | 7.63 |
4H+1L | 6.12 | 5.83 | 6.01 | 5.99 | 6.24 | |
3H+2L | 5.01 | 5.07 | 4.91 | 5.00 | 4.85 | |
2H+3L | 3.70 | 3.71 | 3.64 | 3.68 | 3.47 | |
1H+4L | 2.13 | 2.18 | 2.15 | 2.15 | 2.08 | |
5L | 0.67 | 0.68 | 0.72 | 0.69 | 0.69 | |
DD | 5H | 9.49 | 9.42 | 9.55 | 9.49 | 9.49 |
4H+1L | 8.28 | 8.44 | 8.62 | 8.45 | 7.69 | |
3H+2L | 6.08 | 6.02 | 6.02 | 6.04 | 5.89 | |
2H+3L | 4.06 | 4.11 | 4.15 | 4.11 | 4.08 | |
1H+4L | 2.28 | 2.13 | 2.25 | 2.22 | 2.28 | |
5L | 0.50 | 0.47 | 0.47 | 0.48 | 0.48 |
项目 | rs | Passing-Bablok回归分析 | Bland-Altman图 | |||
---|---|---|---|---|---|---|
斜率(95%CI) | 截距(95%CI) | 偏移(95%CI)/% | 参考区间/% | |||
PT | 0.990 | 1.024 8(0.989 4~1.057 8) | -0.060 7(-0.658 1~0.719 1) | 2.6(1.4~3.8) | -7.5~7.5 | |
APTT | 0.916 | 1.261 8(1.123 4~1.435 6) | -18.121 6(-26.003 9~-12.522 1) | -18.9(-22.9~-14.9) | -7.5~7.5 | |
Fib | 0.989 | 1.013 7(0.964 3~1.056 7) | -0.146 4(-0.253 8~0.000 4) | -8.2(-10.1~-6.0) | -10.0~10.0 |
项目 | rs | Passing-Bablok回归分析 | Bland-Altman图 | |||
---|---|---|---|---|---|---|
斜率(95%CI) | 截距(95%CI) | 偏移(95%CI)/% | 参考区间/% | |||
PT | 0.990 | 1.024 8(0.989 4~1.057 8) | -0.060 7(-0.658 1~0.719 1) | 2.6(1.4~3.8) | -7.5~7.5 | |
APTT | 0.916 | 1.261 8(1.123 4~1.435 6) | -18.121 6(-26.003 9~-12.522 1) | -18.9(-22.9~-14.9) | -7.5~7.5 | |
Fib | 0.989 | 1.013 7(0.964 3~1.056 7) | -0.146 4(-0.253 8~0.000 4) | -8.2(-10.1~-6.0) | -10.0~10.0 |
[1] | 张强,宗晓龙,李东明,等. 用EP9-A3评价2种血凝分析仪凝血酶原时间检测结果的一致性[J]. 临床检验杂志,2019,37(1):71-74. |
[2] | GEENS T,VERTESSEN F,MALFAIT R,et al.Validation of the Sysmex CS5100 coagulation analyzer and comparison to the Stago STA-R analyzer for routine coagulation parameters[J]. Int J Lab Hematol,2015,37(3):372-381. |
[3] | Clinical and Laboratory Standards Institute. Users verification of precision and estimation of bias;approved guideline-third edition[S]. EP15-A3,CLSI,2014. |
[4] | Clinical and Laboratory Standards Institute. Interference testing in clinical chemistry;approved guideline-second edition[S]. EP7-A2,CLSI,2005. |
[5] | 聂滨,陶天陆,黄涛,等. 应用EP7-A2文件评价免疫比浊法测定D-二聚体抗脂浊能力[J]. 检验医学,2015,30(4):324-326. |
[6] | Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures:a statistical approach;approved guideline[S]. EP6-A,CLSI,2003. |
[7] | 李雯,何爱丽,张雯,等. CS-5100全自动血凝仪检测抗凝血酶Ⅲ、蛋白C、蛋白S活性的性能验证[J]. 检验医学,2018,33(11):1009-1012. |
[8] | Clinical and Laboratory Standards Institute. Defining establishing and verifying reference intervals in the clinical laboratory;approved guideline-third edition[S]. C28-A3,CLSI,2008. |
[9] | Clinical and Laboratory Standards Institute. Measurement procedure comparison and bias estimation using patient samples;approved guideline-third edition[S]. EP9-A3,CLSI,2013. |
[10] | NOGUÉS-SABATÉ A,AVILES-JURADO F X,RUIZ-SEVILLA L,et al. Intra and interobserver agreement of narrow band imaging for the detection of head and neck tumors[J]. Eur Arch Otorhinolaryngol,2018,275(9):2349-2354. |
[11] | 王霞,毛志刚,周静,等. 应用活化部分凝血活酶时间监测普通肝素抗凝治疗范围的建立[J]. 现代预防医学,2010,37(22):4374-4375. |
[12] | Clinical and Laboratory Standards Institute. One-stage prothrombin time(PT)test and activated partial thromboplastin time(APTT)test;approved guideline-second edition[S]. H47-A2,CLSI,2008. |
[13] | Clinical and Laboratory Standards Institute. Protocol for the evaluation,validation,and implementation of coagulometers;approved guideline[S]. H57-A,CLSI,2008. |
[14] | FRITSMA G A,DEMBITZER F R,RANDHAWA A,et al.Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization[J]. Am J Clin Pathol,2012,137(6):904-908. |
[15] | 寿玮龄,陈倩,张建平,等. APTT ACTIN试剂和APTT ACTIN FSL试剂临床应用比较[J]. 临床检验杂志,2019,37(6):456-460. |
[16] | MARTINUZZO M,BARRERA L,RODRIGUEZ M.Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?[J]. Int J Lab Hematol,2015,37(6):853-860. |
[17] | TREICHL B,BACHLER M,LORENZ I,et al.Efficacy of argatroban in critically ill patients with heparin resistance:a retrospective analysis[J]. Semin Thromb Hemost,2015,41(1):61-67. |
[1] | ZENG Yanfen, WU Quanming, ZHOU Huan, ZHANG Qiuqin, KANG Yanli, LI Yao, CHEN Xijun, HUANG Jiangang, CHEN Falin. Determination limits of a severe acute respiratory syndrome coronavirus 2 nucleic acid determination reagent in 4 determination systems [J]. Laboratory Medicine, 2023, 38(3): 261-266. |
[2] | HUANG Zhongqiang, DAI Di, HOU Tieying, LIN Faquan, LU Zhiming, LIU Xiaoqi, SHEN Minna, WU Jie, ZHANG Pingan, ZHOU Jun, XIAO Yanqun, WANG Hualiang. Multicenter performance evaluation of a 7-microRNA test kit [J]. Laboratory Medicine, 2023, 38(11): 1075-1081. |
[3] | HAO Yexia, ZHENG Xuan, HU Yuanping, ZHANG Litao, YAN Xinsheng, CAO Shuzheng, WANG Zhang, ZHANG Zhenlu. Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin anticoagulation strategy after cardiac valve replacement [J]. Laboratory Medicine, 2019, 34(2): 126-129. |
[4] | XIA Yong, XUE Hao, LI Mingyang, JI Ling. Hook effect performance verification in laboratory-developed turbidimetric immunoassay systems [J]. Laboratory Medicine, 2018, 33(12): 1132-1135. |
[5] | LI Wen, HE Aili, ZHANG Wen, ZHOU Ting. Performance verification of CS-5100 automatic blood coagulation analyzer for the determinations of antithrombin Ⅲ,protein C and protein S activities [J]. Laboratory Medicine, 2018, 33(11): 1009-1012. |
[6] | ZHU Yuqing, ZHU Lingfeng, ZHAO Xiaojun, XU Chong, SHAO Weijie, CAO Danru, LU Yinhua. Establishment and performance evaluation of liquid-chromatography tandem-mass spectrometry for determining serum cortisone [J]. Laboratory Medicine, 2017, 32(6): 524-530. |
[7] | FU Jie, SU Peng, JIANG Xingyu, PU Xiaoyun. Performance verification of Addcare Elisa800 automatic enzyme immunoassay workstation and its clinical application [J]. Laboratory Medicine, 2016, 31(9): 797-800. |
[8] | FANG Qing. The determination of D-dimer by dual particle size latex immunoturbidimetry [J]. Laboratory Medicine, 2016, 31(9): 801-806. |
[9] | CHEN Shuying, CHEN Jian, LIN Yong, SHI Chaohui. Methodology verification on the performance of BD FACSCantoⅡflow cytometry analyzer [J]. Laboratory Medicine, 2016, 31(5): 405-411. |
[10] | ZHUANG Wenfang, CHEN Yanhong, LUO Ruiping, WU Jing, XUAN Binbin, CAO Yanan, YANG Li, SHENG Huiming. Evaluation on the stable dose prediction accuracy of Warfarin anticoagulant therapy by pharmacogenetics among Shanghai patients [J]. Laboratory Medicine, 2015, 30(7): 697-702. |
[11] | WU Jiong, LI Jun, WU Shengchao, ZHANG Chunyan, SONG Binbin, WANG Beili, GUO Wei, PAN Baishen. Research on single nucleotide polymorphism with initial anticoagulative effect and maintenance dose of Warfarin [J]. Laboratory Medicine, 2015, 30(7): 707-714. |
[12] | SONG Binbin, QIN Jiaqian, PENG Yingfei, ZHANG Chunyan, WU Jiong, WANG Beili, GUO Wei, PAN Baishen. Establishment on a LC-MS/MS and its performance characteristic evaluation for the determination of serum 25-hydroxyvitamin D [J]. Laboratory Medicine, 2015, 30(5): 416-420. |
[13] | WANG Fang, ZHANG Jun, XU Weijie, YUE Jun, CHEN Xiaoyan, CHEN Jin.. Evaluation on the performance of Sysmex CS 5100 automatic blood coagulation analyzer [J]. Laboratory Medicine, 2015, 30(2): 177-180. |
[14] | SHI Mei, SHEN Yuhua, SHI Weifeng. Comparison analysis on the results of SYSMEX CA1500 and SYSMEX CA7000 coagulation analyzers [J]. , 2014, 29(9): 961-963. |
[15] | YAN Hongbin, ZHENG Shanluan, HAO Xiaoke. Performance evaluation and reference range adjustment for 6 coagulation indicators of SYSMEX CS5100 coagulation analyzer [J]. , 2014, 29(9): 964-968. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||